170 related articles for article (PubMed ID: 23041828)
1. Mesothelioma with signet-ring cell features: report of 23 cases.
Ordóñez NG
Mod Pathol; 2013 Mar; 26(3):370-84. PubMed ID: 23041828
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study.
Ordóñez NG
Mod Pathol; 2006 Mar; 19(3):417-28. PubMed ID: 16415794
[TBL] [Abstract][Full Text] [Related]
3. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study.
Ordóñez NG
Mod Pathol; 2006 Jan; 19(1):34-48. PubMed ID: 16056246
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
Ordóñez NG; Sahin AA
Hum Pathol; 2014 Jul; 45(7):1529-40. PubMed ID: 24816068
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
Ordóñez NG
Hum Pathol; 2004 Jun; 35(6):697-710. PubMed ID: 15188136
[TBL] [Abstract][Full Text] [Related]
7. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases.
Ordóñez NG
Mod Pathol; 2006 Mar; 19(3):373-83. PubMed ID: 16400322
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas.
Foster MR; Johnson JE; Olson SJ; Allred DC
Arch Pathol Lab Med; 2001 Oct; 125(10):1316-20. PubMed ID: 11570906
[TBL] [Abstract][Full Text] [Related]
9. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical diagnosis of epithelioid mesothelioma: an update.
Ordóñez NG
Arch Pathol Lab Med; 2005 Nov; 129(11):1407-14. PubMed ID: 16253021
[TBL] [Abstract][Full Text] [Related]
11. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
Haninger DM; Kloecker GH; Bousamra Ii M; Nowacki MR; Slone SP
Mod Pathol; 2014 Apr; 27(4):535-42. PubMed ID: 24030743
[TBL] [Abstract][Full Text] [Related]
12. Mesotheliomas with small cell features: report of eight cases.
Ordóñez NG
Mod Pathol; 2012 May; 25(5):689-98. PubMed ID: 22222641
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic mesothelioma: report of 10 cases.
Ordóñez NG
Mod Pathol; 2012 Jul; 25(7):1011-22. PubMed ID: 22388762
[TBL] [Abstract][Full Text] [Related]
14. Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
Üçer Ö; Dağli AF; Kiliçarslan A; Artaş G
Turk Patoloji Derg; 2013; 29(2):94-100. PubMed ID: 23661345
[TBL] [Abstract][Full Text] [Related]
15. Signet ring cell mesothelioma; A diagnostic challenge.
Wang H; Herath C
Pathol Res Pract; 2019 Jul; 215(7):152462. PubMed ID: 31146976
[TBL] [Abstract][Full Text] [Related]
16. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report.
Choi E; Lewis AL; Takei H; Ro JY
Int J Clin Exp Pathol; 2012; 5(9):972-6. PubMed ID: 23119115
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity.
Yaziji H; Battifora H; Barry TS; Hwang HC; Bacchi CE; McIntosh MW; Kussick SJ; Gown AM
Mod Pathol; 2006 Apr; 19(4):514-23. PubMed ID: 16554731
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4.
Naso JR; Churg A
Hum Pathol; 2020 Jun; 100():10-14. PubMed ID: 32333920
[TBL] [Abstract][Full Text] [Related]
20. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
Mawas AS; Amatya VJ; Kushitani K; Kai Y; Miyata Y; Okada M; Takeshima Y
Sci Rep; 2018 Jan; 8(1):134. PubMed ID: 29317712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]